Metabolic adaptation drives arsenic trioxide resistance in acute promyelocytic leukemia

Molybdenum Trioxide purified Antimony Trioxide extrapurified AR Molybdenum Trioxide extrapurified AR Pyridine-Sulfur Trioxide Complex Lead Titanium Trioxide Sulfur Trioxide Pyridine Complex

Acquired genetic mutations can confer resistance to arsenic trioxide (ATO) within the remedy of acute promyelocytic leukemia (APL). Nonetheless, such resistance-conferring mutations are uncommon and don’t clarify most illness recurrence seen within the clinic.
Now we have generated secure ATO-resistant promyelocytic cell strains which are additionally much less delicate to ATRA and the mix of ATO and ATRA in comparison with the delicate cell line.
Characterization of those in-house generated resistant cell strains confirmed important variations in immunophenotype, drug transporter expression, anti-apoptotic protein dependence, and PML-RARA mutation. Gene expression profiling revealed outstanding dysregulation of the mobile metabolic pathways in these ATO resistant APL cell strains.
Glycolytic inhibition by 2-DG was enough and corresponding to the usual of care (ATO) in focusing on the delicate APL cell line. 2-DG was additionally efficient within the in vivo transplantable APL mouse mannequin; nevertheless, it didn’t have an effect on the ATO resistant cell strains. In distinction, the resistant cell strains had been considerably affected by compounds focusing on the mitochondrial respiration when mixed with ATO, regardless of the ATO resistance-conferring genetic mutations or the sample of their anti-apoptotic protein dependency.
Our information exhibit that the addition of mitocans together with ATO can overcome ATO resistance. We additional present that this mixture has the potential within the remedy of non-M3 AML and relapsed APL. The interpretation of this strategy within the clinic must be explored additional.

Colorimetric Comparability of Inside Bleaching with and with out Eradicating Mineral Trioxide Mixture (MTA) on Induced Coronal Tooth Discoloration by MTA

This examine aimed to colorimetric comparability of inner bleaching with and with out eradicating mineral trioxide combination (MTA) on induced coronal tooth discoloration by MTA cement. On this experimental examine, twenty human tooth had been ready.
An OrthoMTA barrier was positioned 1 mm beneath the CEJ. The tooth had been restored with composite resin and had been positioned within the ageing accelerator machine. Then, the specimens had been divided into two teams (n = 10); in group A, a part of the OrthoMTA was eliminated and the glass ionomer was positioned on the OrthoMTA, and in group B, the OrthoMTA remained intact. Inside bleaching was carried out 5 instances in 6-day intervals utilizing 37% carbamide peroxide gel.
Coloration dedication was carried out in 5 phases: baseline, after OrthoMTA discoloration, earlier than OrthoMTA elimination, after OrthoMTA elimination, and after bleaching remedy periods. In group A, eight specimens reached to ∆E < 3.Three after 2 instances inner bleaching remedy, and in group B, 5 specimens reached to ∆E < 3.Three with nearly Three bleaching periods (p > 0.05).
Moreover, 5 specimens reached to the preliminary colour (baseline) after bleaching remedy, Four specimens in group A and 1 specimen in group B. After OrthoMTA elimination, 2 specimens in group A reached to ∆E < 3.3. There was no important distinction between teams with or with out OrthoMTA elimination (p=0.06). Though, the specimens with OrthoMTA elimination required fewer bleaching remedy periods, and the imply worth of ∆E was decrease on this group.
 Metabolic adaptation drives arsenic trioxide resistance in acute promyelocytic leukemia
Iridium in Tungsten Trioxide Matrix as an Environment friendly Bi-Purposeful Electrocatalyst for General Water Splitting in Acidic Media
Electrocatalytic water splitting in acidic media is a promising technique for grid scale manufacturing of hydrogen utilizing renewable power, however challenges nonetheless exist within the growth of superior catalysts with each excessive exercise and stability.
Herein, it’s reported that iridium doped tungsten trioxide (Ir-doped WO3 ) with arrayed construction and confined Ir websites is an environment friendly and sturdy bi-functional catalyst for general acidic water splitting. A low overpotential (258 mV) is required to realize an oxygen evolution response present density of 10 mA cm-2 in 0.5 m H2 SO4 answer.
In the meantime, Ir-doped WO3 processes the same intrinsic exercise to Pt/C towards hydrogen evolution response. General water splitting utilizing the bi-functional Ir-doped WO3 catalyst exhibits low cell voltages of 1.56 and 1.68 V to drive the present densities of 10 and 100 mA cm-2 , respectively, with solely 16 mV decay noticed after 60 h steady electrolysis underneath the present density of 100 mA cm-2 . Structural evaluation and density useful idea calculation point out that the adjusted coordination setting of Ir inside the crystalline matrix of WO3 contributes to the excessive exercise and sturdiness.

Pulpal response to mineral trioxide combination containing phosphorylated pullulan-based capping materials

This examine aimed to judge the pulpal responses of monkey’s pulp after direct pulp capping (DPC) with the novel mineral trioxide combination containing phosphorylated pullulan-based materials (MTAPPL). Seventy-two tooth had been randomly divided into 4 teams: MTAPPL; Nex-Cem MTA (NX);
TheraCal LC (TH); and Dycal (DY). Histopathological adjustments within the pulps had been noticed at days 3, 7 and 70. On day 3, delicate inflammatory responses had been noticed within the MTAPPL, no to reasonable inflammatory responses within the TH, whereas reasonable inflammatory responses within the NX and DY. No mineralized tissue formation (MTF) was noticed in all teams.
On day 7, no or delicate inflammatory responses had been noticed in all teams. Preliminary MTF was noticed aside from DY. No irritation with full MTF together with presence of odontoblast-like cells was noticed within the MTAPPL, NX and TH teams at day 70. These findings point out that MTAPPL might be an environment friendly DPC materials.

Liquiritigenin protects towards arsenic trioxide-induced liver damage by inhibiting oxidative stress and enhancing mTOR-mediated autophagy

Liquiritigenin (LQ) has protecting results towards varied hepatotoxicities. Nonetheless, its particular position on arsenic trioxide (ATO)-induced hepatotoxicity and the associated biomolecular mechanisms stay unclear.
The aim of this examine is to discover the protecting actions of LQ on ATO-induced hepatotoxicity and its biomolecular mechanisms in mice. LQ was administered orally at 20 and 40 mg/kg per day for seven consecutive days with an intraperitoneal injection of ATO (5 mg/kg). Liver damage was induced by ATO and was alleviated by remedy with LQ as mirrored by diminished histopathological injury of liver and decreased serum ALT, AST, and ALP ranges.
The era of intracellular ROS induced by ATO was attenuated after LQ remedy. The degrees of SOD, CAT, and GSH had been elevated with LQ administration whereas MDA ranges decreased. LQ mitigated elevated TNF-α and IL-6 ranges in addition to the hepatic mitochondrial injury brought on by ATO. Furthermore, LQ upregulated the expression of LC3-II and enhanced autophagy within the liver of ATO-induced mice. Additional research indicated that LQ considerably suppressed the expression of p-PI3K, p-AKT, and p-mTOR in ATO-induced mice.

Molybdenum Cofactor Sulfurase (MOCOS) Antibody

abx235263-100ug 100 ug
EUR 577.2

Molybdenum Cofactor Synthesis 2 (MOCS2) Antibody

20-abx135733
  • EUR 493.20
  • EUR 710.40
  • EUR 218.40
  • EUR 376.80
  • 100 ul
  • 200 ul
  • 20 ul
  • 50 ul

Molybdenum Cofactor Synthesis 1 (MOCS1) Antibody

abx037731-100ug 100 ug
EUR 469.2

Molybdenum Cofactor Synthesis 1 (MOCS1) Antibody

20-abx005887
  • EUR 493.20
  • EUR 710.40
  • EUR 218.40
  • EUR 376.80
  • 100 ul
  • 200 ul
  • 20 ul
  • 50 ul

Molybdenum Cofactor Synthesis 1 (MOCS1) Antibody

20-abx131326
  • EUR 526.80
  • EUR 159.60
  • EUR 1479.60
  • EUR 710.40
  • EUR 393.60
  • 100 ug
  • 10 ug
  • 1 mg
  • 200 ug
  • 50 ug

Molybdenum Cofactor Synthesis 1 (MOCS1) Antibody

20-abx131327
  • EUR 510.00
  • EUR 159.60
  • EUR 1446.00
  • EUR 693.60
  • EUR 393.60
  • 100 ug
  • 10 ug
  • 1 mg
  • 200 ug
  • 50 ug

Molybdenum Cofactor Synthesis 2 (MOCS2) Antibody

20-abx113871
  • EUR 878.40
  • EUR 477.60
  • 150 ul
  • 50 ul

Molybdenum Cofactor Synthesis 2 (MOCS2) Antibody

abx028710-400ul 400 ul
EUR 627.6

Molybdenum Cofactor Synthesis 2 (MOCS2) Antibody

abx028710-80l 80 µl
EUR 343.2

Molybdenum Cofactor Synthesis 1 (MOCS1) Antibody

abx025653-400ul 400 ul
EUR 627.6

Molybdenum Cofactor Synthesis 1 (MOCS1) Antibody

abx025653-80l 80 µl
EUR 343.2

Molybdenum Cofactor Synthesis 2 (MOCS2) Antibody

abx036894-100ug 100 ug
EUR 469.2

Molybdenum Cofactor Synthesis 2 (MOCS2) Antibody

20-abx321401
  • EUR 526.80
  • EUR 393.60
  • 100 ul
  • 50 ul

Molybdenum Cofactor Synthesis 2 (MOCS2) Antibody

20-abx321402
  • EUR 526.80
  • EUR 393.60
  • 100 ul
  • 50 ul

Molybdenum Cofactor Synthesis 1 (MOCS1) Antibody

20-abx321947
  • EUR 526.80
  • EUR 393.60
  • 100 ul
  • 50 ul

Molybdenum Cofactor Synthesis 1 (MOCS1) Antibody

20-abx322547
  • EUR 526.80
  • EUR 393.60
  • 100 ul
  • 50 ul

Molybdenum Cofactor Synthesis 2 (MOCS2) Antibody

20-abx304514
  • EUR 493.20
  • EUR 2214.00
  • EUR 718.80
  • EUR 218.40
  • EUR 360.00
  • 100 ug
  • 1 mg
  • 200 ug
  • 20 ug
  • 50 ug

Molybdenum Cofactor Synthesis 2 (MOCS2) Antibody

abx235264-100ug 100 ug
EUR 577.2

Recombinant Molybdenum Cofactor Synthesis 1 (MOCS1)

4-RPC623Hu01
  • EUR 603.84
  • EUR 285.60
  • EUR 1934.40
  • EUR 724.80
  • EUR 1329.60
  • EUR 480.00
  • EUR 4656.00
  • 100 ug
  • 10ug
  • 1 mg
  • 200 ug
  • 500 ug
  • 50ug
  • 5 mg
Description: Recombinant Human Molybdenum Cofactor Synthesis 1 expressed in: E.coli

Recombinant Molybdenum Cofactor Synthesis 1 (MOCS1)

4-RPC623Mu01
  • EUR 550.08
  • EUR 271.20
  • EUR 1732.80
  • EUR 657.60
  • EUR 1195.20
  • EUR 444.00
  • EUR 4152.00
  • 100 ug
  • 10ug
  • 1 mg
  • 200 ug
  • 500 ug
  • 50ug
  • 5 mg
Description: Recombinant Mouse Molybdenum Cofactor Synthesis 1 expressed in: E.coli

AAS Molybdenum Std 1000ppm in H2O

AAMOH 500ML
EUR 85.5

AAS Molybdenum Std 10000ppm in H2O

AAMOM 500ML
EUR 272.46

ICP Standard Molybdenum H2O 1000ug/ml

PMO2A7 100ML
EUR 106.02

Human Molybdenum cofactor sulfurase (MOCOS) ELISA Kit

abx250798-96tests 96 tests
EUR 801.6

Molybdenum Cofactor Synthesis 2 (MOCS2) Antibody (HRP)

20-abx304515
  • EUR 493.20
  • EUR 2214.00
  • EUR 718.80
  • EUR 218.40
  • EUR 360.00
  • 100 ug
  • 1 mg
  • 200 ug
  • 20 ug
  • 50 ug

Molybdenum Cofactor Synthesis 2 (MOCS2) Antibody (FITC)

20-abx304516
  • EUR 493.20
  • EUR 2214.00
  • EUR 718.80
  • EUR 218.40
  • EUR 360.00
  • 100 ug
  • 1 mg
  • 200 ug
  • 20 ug
  • 50 ug

Molybdenum Cofactor Synthesis 2 (MOCS2) Antibody (Biotin)

20-abx304517
  • EUR 493.20
  • EUR 2214.00
  • EUR 718.80
  • EUR 218.40
  • EUR 360.00
  • 100 ug
  • 1 mg
  • 200 ug
  • 20 ug
  • 50 ug

Human Molybdenum Cofactor Synthesis 1 (MOCS1) Protein

20-abx650079
  • EUR 844.80
  • EUR 343.20
  • EUR 2598.00
  • EUR 994.80
  • EUR 594.00
  • 100 ug
  • 10 ug
  • 1 mg
  • 200 ug
  • 50 ug

Mouse Molybdenum Cofactor Synthesis 1 (MOCS1) Protein

20-abx650080
  • EUR 777.60
  • EUR 326.40
  • EUR 2331.60
  • EUR 910.80
  • EUR 560.40
  • 100 ug
  • 10 ug
  • 1 mg
  • 200 ug
  • 50 ug

Cow Molybdenum cofactor sulfurase (MOCOS) ELISA Kit

abx516487-96tests 96 tests
EUR 1093.2

Mouse Molybdenum cofactor sulfurase (MOCOS) ELISA Kit

abx516489-96tests 96 tests
EUR 886.8

Bovine MOCOS/ Molybdenum cofactor sulfurase ELISA Kit

E0183Bo 1 Kit
EUR 860.4

Human MOCOS(Molybdenum cofactor sulfurase) ELISA Kit

EH1514 96T
EUR 681.12
Description: Method of detection: Double Antibody, Sandwich ELISA;Reacts with: Homo sapiens;Sensitivity: 0.188 ng/ml

Human MOCOS/ Molybdenum cofactor sulfurase ELISA Kit

E1626Hu 1 Kit
EUR 726

Mouse Mocos/ Molybdenum cofactor sulfurase ELISA Kit

E0967Mo 1 Kit
EUR 758.4

ELISA kit for Human Molybdenum cofactor sulfurase

EK3232 96 tests
EUR 663.6
Description: Enzyme-linked immunosorbent assay kit for quantification of Human Molybdenum cofactor sulfurase in samples from serum, plasma, tissue homogenates and other biological fluids.

Bovine Molybdenum cofactor sulfurase, MOCOS ELISA KIT

ELI-19415b 96 Tests
EUR 1113.6

Human Molybdenum cofactor sulfurase, MOCOS ELISA KIT

ELI-20833h 96 Tests
EUR 988.8

Mouse Molybdenum cofactor sulfurase, Mocos ELISA KIT

ELI-16543m 96 Tests
EUR 1038

ICP Std Molybdenum 1000ug/mL in H2O

PMO2C1L 1L
EUR 493.62

Kinesis Hollow Cathode Lamp Molybdenum 37mm Std

CHR5781 EACH
EUR 267.9

Kinesis Hollow Cathode Lamp Molybdenum 37mm unicam

CHR5785 EACH
EUR 308.94

Kinesis Hollow Cathode Lamp Molybdenum 37mm Varian

CHR5787 EACH
EUR 308.94

Kinesis Hollow Cathode Lamp Molybdenum 50mm Standard

CHR5789 EACH
EUR 351.12

ICP Std Molybdenum 10000ug/mL in H2O

RPMO4B7 250ML
EUR 189.24

Purified GFP

AG45-0205-Z 0.1 mg
EUR 273.6

Ovalbumin, purified

O705084 1g
EUR 80.88

Purified Water

H2O1 1L
EUR 15.96

Purified Water

H2O10 10L
EUR 78.66

Purified Water

H2O25 25L
EUR 69.54

Purified Water

H2O5 5L
EUR 22.8

Human Molybdenum Cofactor Synthesis 2 (MOCS2) ELISA Kit

abx381488-96tests 96 tests
EUR 1093.2

Molybdenum Cofactor Synthesis 1 (MOCS1) Polyclonal Antibody (Human)

4-PAC623Hu01
  • EUR 296.40
  • EUR 3012.00
  • EUR 750.00
  • EUR 372.00
  • EUR 256.80
  • 100ul
  • 10ml
  • 1ml
  • 200ul
  • 20ul
Description: A Rabbit polyclonal antibody against Human Molybdenum Cofactor Synthesis 1 (MOCS1)

Molybdenum Cofactor Synthesis 1 (MOCS1) Polyclonal Antibody (Mouse)

4-PAC623Mu01
  • EUR 301.20
  • EUR 3091.20
  • EUR 768.00
  • EUR 379.20
  • EUR 258.00
  • 100ul
  • 10ml
  • 1ml
  • 200ul
  • 20ul
Description: A Rabbit polyclonal antibody against Mouse Molybdenum Cofactor Synthesis 1 (MOCS1)

MOCS2 Molybdenum Cofactor Synthesis 2 Human Recombinant Protein

PROTO96033-1 Regular: 10ug
EUR 380.4
Description: MOCS2 Human Recombinant produced in E. coli is a single polypeptide chain containing 224 amino acids (1-188) and having a molecular mass of 25.0 kDa.;MOCS2 is fused to a 36 amino acid His-tag at N-terminus & purified by proprietary chromatographic techniques.

ICP Std Molybdenum 100ug/mL in 2% NH4OH

PMO1A7 100ML
EUR 189.24

ICP Std Molybdenum 100ug/mL in 2% NH4OH

PMO1C3 500ML
EUR 291.84

ICP Std Molybdenum 1000ug/mL in 1% HCl

PMO2A11 100ML
EUR 107.16

ICP Std Molybdenum 1000ug/mL in 2% NH4OH

PMO2B7 250ML
EUR 171

ICP Std Molybdenum 1000ug/mL in 2% NH4OH

PMO2C7 500ML
EUR 310.08

ICP Std Molybdenum 10000ug/mL in 2% NH4OH

PMO4A7 100ML
EUR 184.68

ICP Std Molybdenum 10000ug/mL in 3.5% NH4OH

PMO4B4-500ML 500ML
EUR 739.86

Molybdenum Cofactor Synthesis 1 (MOCS1) Polyclonal Antibody (Human), APC

4-PAC623Hu01-APC
  • EUR 414.00
  • EUR 3930.00
  • EUR 1094.40
  • EUR 528.00
  • EUR 262.80
  • 100ul
  • 10ml
  • 1ml
  • 200ul
  • 20ul
Description: A Rabbit polyclonal antibody against Human Molybdenum Cofactor Synthesis 1 (MOCS1). This antibody is labeled with APC.

Molybdenum Cofactor Synthesis 1 (MOCS1) Polyclonal Antibody (Human), Biotinylated

4-PAC623Hu01-Biotin
  • EUR 373.20
  • EUR 2952.00
  • EUR 872.40
  • EUR 457.20
  • EUR 262.80
  • 100ul
  • 10ml
  • 1ml
  • 200ul
  • 20ul
Description: A Rabbit polyclonal antibody against Human Molybdenum Cofactor Synthesis 1 (MOCS1). This antibody is labeled with Biotin.

Molybdenum Cofactor Synthesis 1 (MOCS1) Polyclonal Antibody (Human), Cy3

4-PAC623Hu01-Cy3
  • EUR 502.80
  • EUR 5190.00
  • EUR 1410.00
  • EUR 654.00
  • EUR 301.20
  • 100ul
  • 10ml
  • 1ml
  • 200ul
  • 20ul
Description: A Rabbit polyclonal antibody against Human Molybdenum Cofactor Synthesis 1 (MOCS1). This antibody is labeled with Cy3.

Molybdenum Cofactor Synthesis 1 (MOCS1) Polyclonal Antibody (Human), FITC

4-PAC623Hu01-FITC
  • EUR 355.20
  • EUR 3168.00
  • EUR 900.00
  • EUR 446.40
  • EUR 234.00
  • 100ul
  • 10ml
  • 1ml
  • 200ul
  • 20ul
Description: A Rabbit polyclonal antibody against Human Molybdenum Cofactor Synthesis 1 (MOCS1). This antibody is labeled with FITC.

Molybdenum Cofactor Synthesis 1 (MOCS1) Polyclonal Antibody (Human), HRP

4-PAC623Hu01-HRP
  • EUR 379.20
  • EUR 3426.00
  • EUR 968.40
  • EUR 477.60
  • EUR 247.20
  • 100ul
  • 10ml
  • 1ml
  • 200ul
  • 20ul
Description: A Rabbit polyclonal antibody against Human Molybdenum Cofactor Synthesis 1 (MOCS1). This antibody is labeled with HRP.

Molybdenum Cofactor Synthesis 1 (MOCS1) Polyclonal Antibody (Human), PE

4-PAC623Hu01-PE
  • EUR 355.20
  • EUR 3168.00
  • EUR 900.00
  • EUR 446.40
  • EUR 234.00
  • 100ul
  • 10ml
  • 1ml
  • 200ul
  • 20ul
Description: A Rabbit polyclonal antibody against Human Molybdenum Cofactor Synthesis 1 (MOCS1). This antibody is labeled with PE.

Molybdenum Cofactor Synthesis 1 (MOCS1) Polyclonal Antibody (Mouse), APC

4-PAC623Mu01-APC
  • EUR 421.20
  • EUR 4038.00
  • EUR 1122.00
  • EUR 538.80
  • EUR 266.40
  • 100ul
  • 10ml
  • 1ml
  • 200ul
  • 20ul
Description: A Rabbit polyclonal antibody against Mouse Molybdenum Cofactor Synthesis 1 (MOCS1). This antibody is labeled with APC.

Molybdenum Cofactor Synthesis 1 (MOCS1) Polyclonal Antibody (Mouse), Biotinylated

4-PAC623Mu01-Biotin
  • EUR 379.20
  • EUR 3031.20
  • EUR 892.80
  • EUR 464.40
  • EUR 265.20
  • 100ul
  • 10ml
  • 1ml
  • 200ul
  • 20ul
Description: A Rabbit polyclonal antibody against Mouse Molybdenum Cofactor Synthesis 1 (MOCS1). This antibody is labeled with Biotin.

Molybdenum Cofactor Synthesis 1 (MOCS1) Polyclonal Antibody (Mouse), Cy3

4-PAC623Mu01-Cy3
  • EUR 512.40
  • EUR 5334.00
  • EUR 1446.00
  • EUR 668.40
  • EUR 304.80
  • 100ul
  • 10ml
  • 1ml
  • 200ul
  • 20ul
Description: A Rabbit polyclonal antibody against Mouse Molybdenum Cofactor Synthesis 1 (MOCS1). This antibody is labeled with Cy3.

Molybdenum Cofactor Synthesis 1 (MOCS1) Polyclonal Antibody (Mouse), FITC

4-PAC623Mu01-FITC
  • EUR 361.20
  • EUR 3254.40
  • EUR 921.60
  • EUR 454.80
  • EUR 236.40
  • 100ul
  • 10ml
  • 1ml
  • 200ul
  • 20ul
Description: A Rabbit polyclonal antibody against Mouse Molybdenum Cofactor Synthesis 1 (MOCS1). This antibody is labeled with FITC.

Molybdenum Cofactor Synthesis 1 (MOCS1) Polyclonal Antibody (Mouse), HRP

4-PAC623Mu01-HRP
  • EUR 385.20
  • EUR 3519.60
  • EUR 992.40
  • EUR 486.00
  • EUR 250.80
  • 100ul
  • 10ml
  • 1ml
  • 200ul
  • 20ul
Description: A Rabbit polyclonal antibody against Mouse Molybdenum Cofactor Synthesis 1 (MOCS1). This antibody is labeled with HRP.

Molybdenum Cofactor Synthesis 1 (MOCS1) Polyclonal Antibody (Mouse), PE

4-PAC623Mu01-PE
  • EUR 361.20
  • EUR 3254.40
  • EUR 921.60
  • EUR 454.80
  • EUR 236.40
  • 100ul
  • 10ml
  • 1ml
  • 200ul
  • 20ul
Description: A Rabbit polyclonal antibody against Mouse Molybdenum Cofactor Synthesis 1 (MOCS1). This antibody is labeled with PE.

Mocos ELISA Kit| Mouse Molybdenum cofactor sulfurase ELISA Kit

EF015558 96 Tests
EUR 826.8

MOCOS ELISA Kit| Bovine Molybdenum cofactor sulfurase ELISA Kit

EF011614 96 Tests
EUR 826.8

Kinesis Hollow Cathode Lamp Molybdenum 50mm PE AAnalyst (Lumina)

CHR5791 EACH
EUR 454.86

Kinesis Hollow Cathode Lamp Molybdenum Chromium Cobalt 37mm Standard

CHR5793 EACH
EUR 336.3

Anti-SOS Purified

11-522-C025 0.025 mg
EUR 129.6

Anti-SOS Purified

11-522-C100 0.1 mg
EUR 212.4

Anti-PKAc Purified

11-523-C025 0.025 mg
EUR 129.6

Anti-PKAc Purified

11-523-C100 0.1 mg
EUR 212.4

Anti-SHIP1 Purified

11-524-C025 0.025 mg
EUR 129.6

Anti-SHIP1 Purified

11-524-C100 0.1 mg
EUR 212.4

Anti-SHIP1 Purified

11-525-C025 0.025 mg
EUR 129.6

Anti-SHIP1 Purified

11-525-C100 0.1 mg
EUR 212.4

Anti-LST1 Purified

11-528-C025 0.025 mg
EUR 146.4

Anti-LST1 Purified

11-528-C100 0.1 mg
EUR 244.8

Anti-PSMA Purified

11-532-C025 0.025 mg
EUR 151.2

Anti-PSMA Purified

11-532-C100 0.1 mg
EUR 255.6

Anti-CRP Purified

11-537-C100 0.1 mg
EUR 244.8

Anti-PSMA Purified

11-539-C025 0.025 mg
EUR 151.2

Anti-PSMA Purified

11-539-C100 0.1 mg
EUR 255.6

Anti-AHNAK1 Purified

11-540-C025 0.025 mg
EUR 146.4

Anti-AHNAK1 Purified

11-540-C100 0.1 mg
EUR 244.8

Anti-BRG1 Purified

11-541-C025 0.025 mg
EUR 146.4

Anti-BRG1 Purified

11-541-C100 0.1 mg
EUR 244.8

Anti-CPNE7 Purified

11-542-C025 0.025 mg
EUR 151.2

Anti-CPNE7 Purified

11-542-C100 0.1 mg
EUR 255.6

Anti-GRB2 Purified

11-554-C025 0.025 mg
EUR 146.4

Anti-GRB2 Purified

11-554-C100 0.1 mg
EUR 244.8

Anti-AGR3 Purified

11-560-C025 0.025 mg
EUR 178.8

Anti-AGR3 Purified

11-560-C100 0.1 mg
EUR 309.6

Anti-AGR3 Purified

11-561-C025 0.025 mg
EUR 178.8

Anti-AGR3 Purified

11-561-C100 0.1 mg
EUR 309.6

Anti-UBN1 Purified

11-565-C025 0.025 mg
EUR 146.4

Anti-UBN1 Purified

11-565-C100 0.1 mg
EUR 244.8

Anti-GFAP Purified

11-583-C025 0.025 mg
EUR 135.6

Anti-GFAP Purified

11-583-C100 0.1 mg
EUR 223.2

Anti-FoxP3 Purified

11-601-C025 0.025 mg
EUR 163.2

Anti-FoxP3 Purified

11-601-C100 0.1 mg
EUR 277.2

Anti-PRR7 Purified

11-617-C025 0.025 mg
EUR 168

Anti-PRR7 Purified

11-617-C100 0.1 mg
EUR 288

Anti-ABRA1 Purified

11-619-C025 0.025 mg
EUR 146.4

Anti-ABRA1 Purified

11-619-C100 0.1 mg
EUR 244.8

Anti-GRAP2 Purified

11-639-C025 0.025 mg
EUR 146.4

Anti-GRAP2 Purified

11-639-C100 0.1 mg
EUR 244.8

Anti-Notch1 Purified

11-651-C025 0.025 mg
EUR 118.8

Anti-Notch1 Purified

11-651-C100 0.1 mg
EUR 189.6

Anti-PDK1 Purified

11-659-C100 0.1 mg
EUR 244.8

Anti-ZAP70 Purified

11-665-C025 0.025 mg
EUR 129.6

Anti-ZAP70 Purified

11-665-C100 0.1 mg
EUR 212.4

Anti-EGFR Purified

11-680-C025 0.025 mg
EUR 140.4

Anti-EGFR Purified

11-680-C100 0.1 mg
EUR 234

Anti-BrdU Purified

11-682-C025 0.025 mg
EUR 129.6

Anti-BrdU Purified

11-682-C100 0.1 mg
EUR 212.4

Anti-Nitrotyrosine Purified

11-693-C025 0.025 mg
EUR 189.6

Anti-Nitrotyrosine Purified

11-693-C100 0.1 mg
EUR 332.4

Anti-Drebrin Purified

11-694-C025 0.025 mg
EUR 146.4

Anti-Drebrin Purified

11-694-C100 0.1 mg
EUR 244.8

Anti-FOLR2 Purified

11-696-C025 0.025 mg
EUR 118.8

Anti-FOLR2 Purified

11-696-C100 0.1 mg
EUR 189.6

Anti-PCLO Purified

11-698-C025 0.025 mg
EUR 146.4

Anti-PCLO Purified

11-698-C100 0.1 mg
EUR 244.8

Anti-OPAL1 Purified

11-699-C025 0.025 mg
EUR 146.4

Anti-OPAL1 Purified

11-699-C100 0.1 mg
EUR 244.8

Anti-CLIC5 Purified

11-701-C025 0.025 mg
EUR 146.4

Anti-CLIC5 Purified

11-701-C100 0.1 mg
EUR 244.8

Anti-LARGE1 Purified

11-702-C025 0.025 mg
EUR 146.4

Anti-LARGE1 Purified

11-702-C100 0.1 mg
EUR 244.8

Anti-SCIMP Purified

11-704-C025 0.025 mg
EUR 146.4

Anti-SCIMP Purified

11-704-C100 0.1 mg
EUR 244.8

Anti-TFG Purified

11-709-C025 0.025 mg
EUR 146.4

Anti-TFG Purified

11-709-C100 0.1 mg
EUR 244.8

Anti-PDE8A Purified

11-710-C025 0.025 mg
EUR 146.4

Anti-PDE8A Purified

11-710-C100 0.1 mg
EUR 244.8

Anti-NCK1 Purified

11-711-C025 0.025 mg
EUR 146.4

Anti-NCK1 Purified

11-711-C100 0.1 mg
EUR 244.8

Anti-DLL4 Purified

11-717-C025 0.025 mg
EUR 103.2

Anti-DLL4 Purified

11-717-C100 0.1 mg
EUR 157.2

Anti-RLTPR Purified

11-718-C025 0.025 mg
EUR 146.4

Anti-RLTPR Purified

11-718-C100 0.1 mg
EUR 244.8

Anti-NR2F6 Purified

11-719-C025 0.025 mg
EUR 146.4

Anti-NR2F6 Purified

11-719-C100 0.1 mg
EUR 244.8

Anti-ARHGEF4 Purified

11-723-C025 0.025 mg
EUR 129.6

Anti-ARHGEF4 Purified

11-723-C100 0.1 mg
EUR 212.4
In conclusion, our findings present that LQ protects towards ATO-induced hepatotoxicity as a consequence of its antioxidant and anti inflammatory actions and enhancement of autophagy mediated by the PI3K/AKT/mTOR signaling pathway in mice.

Leave a Reply

Your email address will not be published. Required fields are marked *